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ABSTRACT 
 
Differences in health status by socioeconomic position (SEP) tend to be more evident at older ages, suggesting 
the involvement of a biological mechanism responsive to the accumulation of deleterious exposures across the 
lifespan. DNA methylation (DNAm) has been proposed as a biomarker of biological aging that conserves 
memory of endogenous and exogenous stress during life. 
We examined the association of education level, as an indicator of SEP, and lifestyle-related variables with four 
biomarkers of age-dependent DNAm dysregulation: the total number of stochastic epigenetic mutations (SEMs) 
and three epigenetic clocks (Horvath, Hannum and Levine), in 18 cohorts spanning 12 countries. 
The four biological aging biomarkers were associated with education and different sets of risk factors 
independently, and the magnitude of the effects differed depending on the biomarker and the predictor. On 
average, the effect of low education on epigenetic aging was comparable with those of other lifestyle-related 
risk factors (obesity, alcohol intake), with the exception of smoking, which had a significantly stronger effect.  
Our study shows that low education is an independent predictor of accelerated biological (epigenetic) aging 
and that epigenetic clocks appear to be good candidates for disentangling the biological pathways underlying 
social inequalities in healthy aging and longevity. 
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INTRODUCTION 
 
Aging is characterized by a gradual and constant 
increase in health inequalities across socioeconomic 
groups [1, 2], an association based on strong 
epidemiological evidence known as the ‘social gradient 
in health’. On average, individuals with lower 
socioeconomic position (SEP) have lower life 
expectancy, higher risk of age-related diseases, and 
poorer quality of life at older ages compared with less 
disadvantaged groups. Although lifestyles differ by 
SEP, unhealthy habits only partially explain this 
association [3]. 
 
The role of epigenetic mechanisms in response to trauma, 
and evidence for their involvement in intergenerational 
transmission of biological impacts of traumatic stress 
have been proposed to explain how social adversity gets 
biologically embedded [4], leading to differences in 
biological functionalities among individuals in different 
social conditions, especially at older ages. Epigenetics, 
specifically DNA methylation (DNAm) has been 
proposed as one of the most powerful biomarkers of 
biological aging and as one of the plausible biological 
mechanisms by which social adversities get ‘under the 
skin’ and affect physiological and cellular pathways 
leading to disease susceptibility [5-7].  
 
Two different mechanisms have been proposed to 
contribute to age-related DNAm changes: ‘epigenetic 
drift’ and the ‘epigenetic clock’ that sometimes are used 
as synonyms even though describe different molecular 
mechanisms [8-10]. Although both are related to aging, 
epigenetic drift represents the trend of increasing 
DNAm variability over time across the whole genome. 
On the contrary, the epigenetic clock refers to specific 
CpG sites identified in specific DNA regions at which 
DNAm levels constantly increase (or decrease 
depending on the site) during aging and can be used to 
predict chronological age with high accuracy [11]. Two 
measures of epigenetic clocks have gained considerable 
popularity, Horvath [11] and Hannum [12], and the 
concept of epigenetic aging acceleration (EAA) has 
been introduced as the difference between predicted 
DNAm age and chronological age. EAA has been 
associated with all-cause mortality, cancer incidence 
and neurodegenerative disorders, as well as non-
communicable disease risk factors such as obesity, poor 
physical activity, unhealthy diet, cumulative lifetime 
stress and infections [13, 14]. Recently, Levine and 
colleagues introduced a ‘next-generation epigenetic 
clock’ that is based on a set of CpGs associated with a 
complex set of clinical measures thought to assess the 
‘phenotypic age’ [15]. Levine EAA was found to 
outperform other measures with regard to the prediction  
of a variety of aging outcomes, including all-cause 
mortality, the incidence of and survival from cancer, 
and physical functioning [15]. 
 
In contrast to EAA, epigenetic drift is a mechanism that 
involves the whole-genome, where age-related genomic 
instability and chromatin deterioration lead to increased 
variability of genome-wide DNAm levels at older ages 
[16]. Different statistical approaches can be used to 
evaluate the impact of epigenetic drift on aging and 
disease susceptibility. For example, Teschendorff and 
colleagues suggested that methods based on differential 
DNAm variability could identify risk markers more 
robustly than statistical measures based on differences 
in mean DNAm levels [17]. Gentilini and colleagues 
developed an analytical approach to identify these 
stochastic epimutations (SEMs) [18] from genome-wide 
DNAm data, showing that the number of SEMs 
increases exponentially with age although there is high 
variability within individuals of the same age. A higher 
number of SEMs was found to be associated with X 
chromosome inactivation skewing in women (an age-
related condition and risk factor for cancer), 
hepatocellular carcinoma tumor staging [18, 19], and 
unhealthy exposure such as cigarette smoking, alcohol 
intake [20] and exposure to toxicants [21], suggesting 
SEMs as possible biomarkers of exposure-related 
accumulation of DNA damage during lifespan.  
 
Given the above, it can be assumed that the various 
epigenetic clocks (Horvath’s, Hannum’s, Levine’s) and 
the total number of SEMs describe different aspects of 
the biological (epigenetic) aging process. We previously 
showed a dose-response relationship between SEP and 
EAA. Further, our results suggest that the effect could 
be partially reversible by improving social conditions 
during life [5]. In addition, ours and two more recent 
studies indicate that childhood SEP might have a 
stronger effect on EAA than adulthood SEP [22, 23]. 
 
Despite extensive research in the field, to date no 
studies have compared the effect of SEP on epigenetic 
aging biomarkers with those of other lifestyle-related 
risk factors for age-related diseases. We aimed to 
systematically investigate the association of education 
level, as a proxy for SEP, with the total number of 
SEMs and ‘accelerated aging’ as assessed using the 
three epigenetic clocks, and to compare the independent 
effect of low education with those of the main 
modifiable risk factors for premature aging: smoking, 
obesity, alcohol intake and physical inactivity, by 
conducting a meta-analysis including data for more than 
16,000 individuals belonging to 18 cohort studies from 
12 different countries worldwide. 
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RESULTS 
 
After quality control and sample filtering, we analyzed 
blood DNAm data from 16,245 individuals from 18 
cohort studies. The main characteristics of the study 
sample are shown in Table 1. For each epigenetic 
outcome, we report the results of a meta-analysis of the 
association with education, smoking, obesity, alcohol 
intake and physical activity in Table 2. Model 1 
includes age, sex, and cohort-specific covariates as 
adjustment variables whereas Model 2 is the fully 
adjusted model (additionally adjusted for smoking, 
BMI, alcohol intake and physical activity). 
 
For the three epigenetic clocks, the estimated 
differences presented in Table 2 (βs) represent the 
change in biological age (in years) compared with the 
reference group. Accordingly, the estimated effects of 
risk factors on SEMs were re-scaled to be expressed in 
years as for the three epigenetic clocks using a two-step 
approach based on the Cohen’s D statistic, described in 
the supplementary text. 
 
Table 1. Study sample descriptive statistics. 
Cohort short 
name Cohort full name Country 
Illumina 
BeadChip N Mean age (min - max) 
Female 
N(%) Reference 
AIRWAVE 
The Airwave 
Health 
Monitoring Study 
UK 
Illumina 
EPIC chip 
(850K) 
1,127 41 (13 - 65) 458 (41%) [46] 
EXPOsOMICS 
'EPIC CVD' 
The European 
Prospective 
Investigation into 
Cancer and 
Nutrition - 
EXPOsOMICS 
subsample 
Italy 
Illumina 
450K 
BeadChip 
313 57 (35 - 75) 167 (53%) [47] 
EPIC 
The European 
Prospective 
Investigation into 
Cancer and 
Nutrition 
Italy 
Illumina 
450K 
BeadChip 
1,803 53 (35 - 75) 1,114 (62%) [48] 
ESTHER 1 
Epidemiological 
investigations on 
chances of 
preventing, 
recognizing early 
and optimally 
treating chronic 
diseases in an 
elderly population 
Germany 
Illumina 
450K 
BeadChip 
1,000 62 (48 - 75) 500 (50%) [49] 
ESTHER 2 
Epidemiological 
investigations on 
chances of 
preventing, 
recognizing early 
and optimally 
treating chronic 
diseases in an 
elderly population 
Germany 
Illumina 
EPIC chip 
(850K) 
864 63 (48 - 75) 390 (45%) [49] 
KORA 
Cooperative 
Health Research 
in the Region of 
Augsburg 
(KORA-F4) 
Germany 
Illumina 
450K 
BeadChip 
1,727 61 (32 - 81) 882 (51%) [50] 
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MCCS 
Melbourne 
Collaborative 
Cohort Study 
Australia 
Illumina 
450K 
BeadChip 
2,817 59 (40 - 70) 1,095 (39%) [51] 
NAS Normative aging study USA 
Illumina 
450K 
BeadChip 
624 72 (55 - 91) 0 (0%) [52] 
NOWAC 
The Norwegian 
Women and 
Cancer Study 
Norway 
Illumina 
450K 
BeadChip 
632 56 (47 - 63) 632 (100%)  
NICOLA 
Northern Ireland 
Cohort 
Longitudinal 
Study of Ageing 
Northern 
Ireland 
Illumina 
EPIC chip 
(850K) 
1,929 64 (40 - 96) 988 (51%) [53] 
RS-Bios Rotterdam Study 1,2 Netherlands 
Illumina 
450K 
BeadChip 
720 68 (52 - 80) 304 (42%) [54] 
RSIII-1 Rotterdam Study 3 Netherlands 
Illumina 
450K 
BeadChip 
730 60 (46 - 89) 335 (46%) [54] 
SAPALDIA 
Swiss Study on 
Air Pollution and 
Lung Diseases in 
Adults 
Switzerland 
Illumina 
450K 
BeadChip 
402 57 (38 - 81) 184 (46%) [55] 
SKIPOGH a 
Swiss Kidney 
Project on Genes 
in Hypertension 
Switzerland 
Illumina 
450K 
BeadChip 
250 51 (26 - 82) 132 (53%) [56] 
SKIPOGH b 
Swiss Kidney 
Project on Genes 
in Hypertension 
Switzerland 
Illumina 
EPIC chip 
(850K) 
451 54 (25 - 89) 231 (51%) [56] 
TERRE 
Case-control 
study of 
Parkinson’s 
disease in French 
farmers (only 
controls were 
used) 
France 
Illumina 
EPIC chip 
(850K) 
174 67 (41 - 76) 80 (46%) [57] 
TILDA 
The Irish 
Longitudinal 
Study on aging 
Ireland 
Illumina 
EPIC chip 
(850K) 
490 62 (50 - 80) 246 (50%) [58] 
YFS Young Finns Study Finland 
Illumina 
450K 
BeadChip 
186 44 (34 - 49) 72 (39%) [59] 
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Education: The level of education was significantly 
associated with the four biomarkers investigated. In 
Model 1 (minimally adjusted), lower educated 
individuals had a higher number of SEMs β = 0.34 
(95% CI 0.11; 0.58), higher Horvath EAA β = 0.22 
(0.03; 0.41), higher Hannum EAA β = 0.34 (0.17; 0.52), 
and higher Levine EAA β = 0.84 (0.50; 1.17), compared 
with the higher educated group who constituted the 
reference category. The observed associations were still 
significant after the inclusion of smoking, BMI, alcohol 
and physical activity in the regression models (Model 
2), but the estimated effects were moderately reduced. 
Comparing the two extreme categories (low vs. high 
education) the estimated effects were: SEMs β = 0.28 
(0.04; 0.51), Horvath EAA β = 0.19 (0.00; 0.39), 
Hannum EAA β = 0.31 (0.14; 0.48), and Levine EAA β 
= 0.60 (0.25; 0.94) in the full multivariable adjusted 
models. Interestingly, the intermediate education group 
ranked between the high and low education group 
supporting a dose-response effect (Table 2).
 
Table 2. Results of linear regressions using epigenetic aging biomarkers as outcomes and lifestyle related risk 
factors as predictors.  
  SEMs HorvathEAA 
  Model 1 Model 2 Model 1 Model 2 
Education 
(ref: High) 
Medium 0.23 (0.02; 0.44)* 0.17 (-0.07; 0.42)  0.11 (-0.07; 0.28)  0.11 (-0.08; 0.29)  
Low 0.34 (0.11; 0.58)** 0.28 (0.04; 0.51)* 0.22 (0.03; 0.41)* 0.19 (0.00; 0.39)+ 
Smoking (ref: 
Never) 
Former 0.32 (0.14; 0.49)*** 0.33 (0.16; 0.51)*** 0.13 (-0.04; 0.29)  0.11 (-0.05; 0.26)  
Current 0.53 (0.32; 0.73)*** 0.51 (0.30; 0.72)*** -0.06 (-0.24; 0.13)  -0.08 (-0.27; 0.12)  
Obesity (ref: 
BMI < 25) 
BMI < 30 -0.01 (-0.18; 0.16)  -0.01 (-0.18; 0.15)  0.37 (0.22; 0.52)*** 0.33 (0.18; 0.48)*** 
BMI ≥ 30 -0.06 (-0.26; 0.15)  -0.07 (-0.27; 0.14)  0.45 (0.27; 0.63)*** 0.43 (0.24; 0.61)*** 
Alcohol (ref: 
Abstainer) 
Occasional -0.12 (-0.31; 0.08)  -0.10 (-0.29; 0.08)  -0.02 (-0.19; 0.15)  0.00 (-0.18; 0.18)  
Habitual 0.22 (-0.05; 0.49)  0.15 (-0.11; 0.4)  0.19 (-0.07; 0.44)  0.25 (0.00; 0.49)* 
Physical 
activity (ref: 
High) 
Medium 0.00 (-0.21; 0.21)  -0.03 (-0.21; 0.15)  0.05 (-0.11; 0.21)  0.08 (-0.09; 0.24)  
Low 0.03 (-0.28; 0.35)  -0.03 (-0.32; 0.26)  0.22 (0.05; 0.39)* 0.22 (0.04; 0.40)* 
  HannumEAA LevineEAA 
  Model 1 Model 2 Model 1 Model 2 
Education 
(ref: High) 
Medium 0.32 (0.14; 0.49)*** 0.27 (0.08; 0.46)** 0.50 (0.22; 0.79)*** 0.31 (-0.05; 0.67)+ 
Low 0.34 (0.17; 0.52)*** 0.31 (0.14; 0.48)*** 0.84 (0.50; 1.17)*** 0.60 (0.25; 0.94)*** 
Smoking (ref: 
Never) 
Former 0.04 (-0.08; 0.16)  0.01 (-0.12; 0.13)  0.60 (0.37; 0.84)*** 0.52 (0.28; 0.77)*** 
Current 0.24 (0.06; 0.42)** 0.17 (0.00; 0.35)* 1.57 (1.31; 1.82)*** 1.41 (1.14; 1.67)*** 
Obesity (ref: 
BMI < 25) 
BMI < 30 0.17 (0.05; 0.28)** 0.15 (0.03; 0.27)* 0.37 (0.13; 0.62)** 0.33 (0.11; 0.55)** 
BMI ≥ 30 0.22 (0.07; 0.36)** 0.20 (0.05; 0.34)* 1.08 (0.79; 1.37)*** 1.01 (0.74; 1.28)*** 
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Alcohol (ref: 
Abstainer) 
Occasional -0.05 (-0.19; 0.09)  0.03 (-0.11; 0.17)  -0.08 (-0.36; 0.20)  0.10 (-0.14; 0.34)  
Habitual 0.14 (-0.03; 0.31)  0.21 (0.04; 0.39)* 0.88 (0.49; 1.26)*** 0.91 (0.57; 1.25)*** 
Physical 
activity (ref: 
High) 
Medium 0.07 (-0.08; 0.22)  0.07 (-0.07; 0.20)  0.16 (-0.17; 0.49)  0.20 (-0.04; 0.44)  
Low 0.08 (-0.15; 0.32)  0.05 (-0.20; 0.30)  0.42 (-0.12; 0.96)  0.31 (-0.13; 0.74)  
*** p < 0.001; ** p < 0.01; * p < 0.05; + p < 0.10 
Model 1 includes age, sex, and cohort specific covariates; Model 2 includes additional adjustment for education, smoking, 
BMI, alcohol and physical activity. 
 
 
Other modifiable risk factors: Current smokers had a 
higher number of SEMs, higher Hannum EAA and 
higher Levine EAA compared with never smokers. The 
estimated effects were slightly reduced in Model 2 
compared with Model 1 when adjusted additionally for 
other covariates. Further, former smokers had 
intermediate outcomes between never and current 
smokers (Table 2). The estimated effect size of the 
association between smoking and epigenetic aging 
biomarkers was comparable to those observed for 
education, except for the magnitude of the association 
with Levine EAA, which was significantly higher: β = 
1.57 (1.31; 1.82)  in  Model 1; β = 1.41 (1.14; 1.67)  in 
Model 2. A similar pattern of associations was observed 
looking at the effects of obesity on epigenetic aging 
biomarkers. Obese individuals (BMI ≥ 30) had higher 
Horvath EAA, higher Hannum EAA, and higher Levine 
EAA. As previously described for education and 
smoking, the effects estimated in Model 2 were slightly 
lower compared with Model 1, and a dose-response 
association was observed. The estimated effects of 
obesity were comparable to those of education except 
for Levine EAA, which was significantly higher: β = 
1.08 (0.79; 1.37) in Model 1; β = 1.01 (0.74; 1.28) in 
Model 2. Looking at alcohol intake, we did not observe 
any significant difference comparing abstainers and 
occasional drinkers, but habitual drinkers had higher 
Horvath EAA, Hannum EAA and Levine EAA. As 
observed for the other risk factors, the higher estimated 
effects were observed for Levine’s indicator: β = 0.88 
(0.49; 1.26) in Model 1; β = 0.91 (0.57; 1.25) in Model 
2. Finally, low physical activity was associated with 
higher Horvath EAA in both Model 1 β = 0.22 (0.05; 
0.39) and Model 2 β = 0.22 (0.04; 0.40). 
 
Figure 1 shows a graphical representation of the results 
(Model 2) using forest plot which allows one to 
compare the effect of each risk factor considered in the 
present paper on the four DNAm outcomes. 
 
In sensitivity analyses, we examined the white blood 
cell (WBC) adjusted epigenetic aging measures 
(described in Methods), and found similar associations 
as the ones described above (Table S1). Further, for 
each risk factor, we evaluated the interaction with age 
and sex. Our results indicated no significant differences 
in associations between men and women, whereas we 
found a significant interaction with age for the 
association of SEMs with education, smoking, and 
obesity, with a significantly stronger effect in older 
individuals (Table S2). 
 
We examined whether SEMs were randomly distributed 
across the genome or are enriched in functional 
genomic regions. We observed overlap between the 
genomic position of SEMs and regions associated with 
open chromatin states, and shores (p=0.03, p=0.02 
respectively, Table S3). Considering the categories 
defined by the Encyclopedia of DNA Elements 
(ENCODE) project with Chromatin Immuno-
Precipitation Sequencing (ChIP-Seq) experiments on 
human embryonic stem cells (hESC), we found 
enrichment of SEMs in ‘inactive/poised promoters’ 
(p<0.0001, Table S4), ‘heterochromatin/low 
signal/CNV’ (p<0.0001, Table S4), and ‘Polycomb-
repressed’ regions (p=0.001, Table S4). Furthermore, 
we found significant overlap with transcription factor 
binding sites (TFBSs) targeted by two members of the 
Polycomb repressive complex-2 (PRC2): EZH2 and 
SUZ12 (p<0.0001, Table S5). 
 
DISCUSSION 
 
Social inequalities in health have been extensively 
reported and accelerated age-dependent DNAm 
dysregulation has been proposed as one of the 
biomolecular mechanisms mediating this association [5, 
24, 25]. In this study, we examined the effect on DNAm 
biomarkers of aging of being in the low education group 
compared with those of other lifestyle-related risk 
factors: smoking, obesity, alcohol intake, and low levels 
of physical activity. We used education as the proxy for 
SEP as it was the only socioeconomic indicator that was 
available in all the cohorts and it is usually completed 
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before the onset of many chronic diseases, therefore 
reducing the risk of reverse causation [26]. Lower edu-
cational attainment was associated with EAA according 
to the ‘first generation’ clocks including Horvath’s and 
Hannum’s. However, previously it was not clear whether 
the observed associations depend on other factors associ-
ated with low education [6, 27].  For example, Karlsson 
Linnér and colleagues argue that the association of 
educational attainment and epigenetic aging is mainly 
mediated by maternal smoking during pregnancy and 
smoking during adulthood [6]. To clarify this issue and 
to increase the epidemiological evidence in the field, we 
 
 
Figure 1. Effect sizes (interpretable as years of increasing/decreasing epigenetic age) of the association between different risk factors 
and four epigenetic aging biomarkers: total number of stochastic epigenetic mutations (SEMs, red), Horvath epigenetic age acceleration 
(orange), Hannum epigenetic age acceleration (green) and Levine epigenetic age acceleration next-generation clock (blue). 
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have examined four biomarkers of age-dependent 
DNAm dysregulation: the total number of SEMs and 
three epigenetic clocks (Horvath, Hannum and Levine).  
 
Although all the biomarkers are related to aging, they 
did not show the same pattern of associations with risk 
factors, intermediate traits and diseases [28, 29], 
suggesting that these biological age predictors may 
reflect different facets of the aging process. The total 
number of SEMs takes into account whole-genome 
epigenetic deregulation during aging, a process known 
as ‘epigenetic drift’, and has been proposed as a 
biomarker of exposure-related accumulation of DNA 
damage during the lifespan [20]. It is necessary to 
clarify that the word ‘epimutation’ is sometimes used in 
a manner that can be misinterpreted. Although some 
literature uses this term to refer to epigenetic changes 
driven by genotype differences, the strict definition of 
epimutation is a heritable change in gene activity that is 
not associated with a DNA mutation, but rather, with 
gain or loss of DNA methylation or other heritable 
modifications of chromatin [30]. Contrary to the 
definition of genetic mutations, epimutations are 
defined as potentially (but not necessarily) reversible 
changes in gene activity not involving DNA mutations, 
but rather, gain or loss of DNA methyl groups 
conserved in cells through mitosis [20, 30, 31]. 
 
In contrast, Horvath’s epigenetic clock is based on 
DNAm levels at a small subset of CpG sites and is 
thought to reflect the biological age of different tissues, 
while Hannum’s epigenetic clock is specific to blood 
samples. Finally, Levine’s next-generation clock is 
computed using a subset of CpGs that were associated 
with several clinical measures representing the health 
status of an individual and has been proposed as a 
biomarker of the individual ‘phenotypic age’ [15]. 
Accordingly, Levine’s measure of age acceleration 
tends to be more variable than the first-generation 
clocks (Horvath and Hannum) as evidenced by the 
finding that the associations based on this marker 
showed, in general, a higher degree of heterogeneity in 
the meta-analysis measured with the I2 and τ2 statistics. 
 
Our results from this meta-analysis of more than 16,000 
individuals support our working hypothesis. We found 
that the four aging biomarkers were associated with 
different sets of risk factors and that the magnitude of 
the associations differed depending on the epigenetic 
aging index. We compared the effects of two nested 
models: the first minimally adjusted model included 
age, sex and cohort-specific covariates as adjustments; 
the second (fully adjusted model) was adjusted for all of 
the risk factors. We did not observe significant 
differences comparing estimates from the two models 
(Table 2), supporting the robustness of the results 
presented. Interestingly, the effect of low education was 
independent from the other risk factors examined, as it 
was significant in both the minimally adjusted and fully 
adjusted models; and the effect sizes were comparable 
to that of the other risk factors examined, with the 
exception of smoking, which had an appreciably larger 
impact on SEMs and Levine’s measure. Two previous 
studies from our group that evaluated the association of 
low SEP with mortality and physical functioning 
documented strong patterning by SEP [32, 33]. The 
current study provides evidence of the potential role of 
epigenetic modifications as mediators of the association 
of low SEP and unhealthy lifestyle habits with adverse 
outcomes at older ages, and further underscores the 
importance of considering SEP as an important life 
course risk factor for premature biological aging. 
 
In sensitivity analyses, we also investigated alternative 
measures of the epigenetic aging biomarkers corrected 
for the proportion of WBC (estimated from whole-
genome DNAm data). Chen and colleagues refer to the 
WBC-adjusted epigenetic aging as an ‘intrinsic’ 
measure of biological aging, which captures cell-
intrinsic properties of the aging process, that exhibit 
some preservation across various cell types and organs 
[34]. Our results indicate no significant differences in 
the results using ‘extrinsic’ (non-WBC-adjusted) vs 
‘intrinsic’ measures.  Similarly, stratified analyses by 
sex indicated no differential effect between men and 
women.  
 
Finally, we evaluated the potential differential effects of 
risk factors by (chronological) age group. We found that 
the effect of education, smoking and BMI on the total 
number of SEMs, and the effect of smoking on Hannum 
EAA was significantly greater for older individuals. 
These results agree with the ‘epigenetic memory’ 
hypothesis according to which epigenetic aging 
biomarkers, particularly SEMs, could reflect the 
accumulation of deleterious exposures during the 
lifespan [35]. 
 
To elucidate the molecular mechanisms involved in 
DNAm dysregulation during aging we investigated 
whether SEMs occurred randomly in the DNA sequence 
or were enriched in regulatory regions. Our findings 
confirmed that epimutations preferentially occur in 
DNA sequences associated with open chromatin (Table 
S3), as previously observed by Ong et al. [36]. 
Furthermore, SEMs were enriched in transcriptionally 
silenced genomic regions such as ‘inactive promoters’, 
‘heterochromatin/low signal/copy number variants 
(CNV)’, and ‘Polycomb-repressed’ regions (Table S4). 
Specifically, SEMs were more likely to occur in 
transcription factor binding sites (TFBSs) targeted by 
two members of Polycomb repressive complex 2 
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(PRC2): EZH2 and SUZ12 (Table S5). The role of 
PCR2 proteins and EZH2 specifically in aging and age-
related diseases has been extensively investigated in 
recent years. Targets of PRC2 proteins are enriched for 
tumor suppressor genes and genes related to 
mental/neurodegenerative disorders [37-39], providing 
a link between aging, age-related DNAm modifications 
and age-related diseases. As an example, 
downregulations of EZH2 and SUZ12 have been 
associated with dysregulation of several PRC2 targets 
including p53, a well-known tumor suppressor gene 
[40]. These results underscore the imperative for further 
research aimed at identifying disease-specific 
epimutation signatures. 
 
In conclusion, we have shown that SEP is associated 
with different biomarkers of biological (epigenetic) 
aging, which may represent complementary aspects of 
the aging process. On average, the impact of low 
education was comparable with that of other lifestyle-
related risk factors, with the exception of smoking, for 
which the effect was more pronounced. Levine’s 
second-generation clock was more strongly associated 
with education and the other risk factors (smoking, 
obesity and alcohol intake) compared with the first-
generation epigenetic clocks and epimutation 
biomarkers. This result is not wholly unexpected 
because Levine’s indicator was explicitly designed with 
a two-step procedure to include both CpG sites 
associated with aging per se, and CpG sites predictive 
of mortality and associated with biomarkers of chronic 
diseases. Given the above, Levine’s epigenetic clock 
appeared to be a strong candidate for future studies 
aiming at disentangling the biological pathways 
underlying social inequalities in healthy aging and 
longevity. We confirmed in a very large cross-cohort, 
cross-country sample, previous observations of 
‘accelerated aging’ in individuals of low SEP [6, 15]. 
To the best of our knowledge this is also the first study 
showing that i) socioeconomic status is associated with 
the total number of stochastic epimutations, which in 
turn is a biomarker of adverse health outcomes at older 
ages; and ii) the impact of low socioeconomic status on 
age-related epigenetic biomarkers is comparable to that 
of the major lifestyle-related and modifiable risk factors 
for age related diseases, with the exception of smoking 
which had a stronger effect on two out of four 
epigenetic biomarkers investigated. 
 
This study also has limitations: variable collection and 
classification were not done in a standardized way for 
all the cohorts. Similarly, for DNA methylation data, 
each cohort used its own method for data normalization 
and batch effect removal. To avoid over-estimation of 
the effects of education and other risk factors on 
epigenetic aging biomarkers, we used a REML method 
that incorporates random study effects around the 
overall mean, to obtain robust global estimates in meta-
analysis.  
 
Education was the only SEP indicator used in this study. 
Critical alternative SEP indicators like income or 
occupational position were not available in all of the 
cohorts used in this meta-analysis. We chose to consider 
all the variables as categorical, with three levels each. 
On the one hand, this procedure helped us to compare 
the effects of low education with that of other risk 
factors, but on the other hand, could lead to a reduction 
in statistical power to detect significant associations. 
The lack of association of epigenetic aging measures 
with low physical activity is not in line with previous 
literature [27] which might be explained by 
heterogeneity in the variable definition across cohorts. 
 
MATERIALS AND METHODS 
 
Participating cohorts 
 
We obtained summary-level association statistics from 
17 independent cohort studies located in Europe, the 
United States and Australia (Table 1). The total sample 
size includes 16,245 individuals of recent European 
ancestry. All participants provided written informed 
consent, and all contributing cohorts confirmed 
compliance with their Local Research Ethics Committees 
or Institutional Review Boards. Each risk factor was 
treated as a categorical variable with three categories 
each; education: ‘High’ (reference), ‘Medium’, ‘Low’; 
smoking: ‘Never’ (reference), ‘Former’, ‘Current’; 
obesity: ‘Normal weight (BMI ≤ 25, reference)’, 
‘Overweight (25 < BMI ≤ 30)’, ‘Obese (BMI > 30)’; 
alcohol consumption: ‘Abstainers’ (reference), 
‘Occasional drinkers’, ‘Habitual drinkers’; physical 
activity: ‘High’ (reference), ‘Medium’, ‘Low’ (see the 
supplementary text for the definition of the categories). 
 
Identification of stochastic epigenetic mutations  
 
We identified SEMs based on the procedure described 
by Gentilini et al. [18]. Briefly, for each CpG, 
considering the distribution of DNAm beta values 
across all samples, we computed the interquartile range 
(IQR) - difference between the third quartile (Q3) and 
the first quartile (Q1) - and we defined a SEM as a 
methylation value lower than Q1-(3×IQR) or greater 
than Q3+(3×IQR). Finally, for each individual, we 
computed the total number of SEMs across all CpGs. 
Since the total number of SEMs increased exponentially 
with age, we used a logarithmic transformation of the 
outcome for all the analyses. In sensitivity analyses, we 
computed the same measure corrected for potential 
confounding by differential WBC proportions among 
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individuals. Specifically, for each CpG we calculated 
the residuals from the regression of DNAm beta values 
on estimated WBC fractions, and then applied the same 
procedure described above. 
 
Computation of epigenetic clock measures 
 
We computed the epigenetic age acceleration (AA) 
measures according to the algorithm described by 
Horvath [11]. Briefly, DNAm age was calculated as a 
weighted average of 353 age-related CpGs (Horvath 
DNAm age), 71 blood specific age-related CpGs 
(Hannum DNAm age), and 513 phenotypic age-related 
CpGs (Levine DNAm age) respectively. Weights were 
obtained using a penalized regression model (Elastic-net 
regularization) [11]. Age acceleration (AA) was defined 
as the difference between epigenetic and chronological 
age. Since AA may be correlated with chronological 
age, the ‘extrinsic’ EAA is defined as the residuals of 
AA on age. For sensitivity analyses, we also computed 
the ‘intrinsic’ epigenetic age acceleration (IEAA), 
defined as the residuals from the linear regression of 
AA on chronological age and WBC percentages [34]. 
Positive values of EAA (which is by definition 
independent of age) indicate accelerated aging and 
negative values decelerated aging. 
 
Association of epigenetic aging measures with risk 
factors 
 
We investigated the association of four biological 
(epigenetic) aging biomarkers with education, smoking, 
obesity, alcohol and physical activity using each 
epigenetic measure as the outcome and risk factors as 
predictors in linear regression models. For each 
outcome and each risk factor, we ran two regression 
models. Model 1 was adjusted for age, sex and cohort-
specific covariates only (see the supplementary text). 
Model 2 included additional adjustment for education, 
smoking, BMI, alcohol intake, physical activity, to 
derive the mutually adjusted estimate for each risk 
factor considered in the present paper. 
 
Each cohort provided the results of the analyses as point 
estimates and 95% confidence intervals based on an R 
script shared with all the data analysts (available in the 
supplementary material). The pooled estimated 
association of risk factors with each outcome were 
obtained by random effect maximum likelihood 
(REML) meta-analysis using the R package metafor 
[41]. Heterogeneity among studies was assessed using 
the I2 and τ2 statistics. 
 
SEMs enrichment analysis 
 
The genomic locations of SEMs were annotated by 
merging the Illumina information on the chromosomal 
position of each probe with ENCODE/NIH Roadmap 
ChIP-Seq data for chromatin states and transcription 
factor binding sites (TFBS) in hESC [42-44]. We 
investigated whether SEMs were randomly distributed 
across the genome, or were enriched in functional 
genomic regions using the procedure implemented in 
the R package regioneR [45]. Briefly, the algorithm is 
specifically designed to test whether a set of genomic 
loci significantly overlap with a set of genomic regions, 
and includes a permutation procedure that controls for 
the type I error rate.  
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SUPPLEMENTARY MATERIAL 
 
Please browse the links in Full Text version of this 
manuscript to see R Scripts. 
 
 
SUPPLEMENTARY METHODS 
 
Cohort description and variable definition 
 
EPIC - Study participants were drawn from the Italian 
component of the European Prospective Investigation into 
Cancer and Nutrition (EPIC) cohort, a large general 
population cohort consisting of ~520,000 individuals, 
with standardized lifestyle and personal history 
questionnaires, measured anthropometric data and blood 
samples collected for DNA extraction [1]. Socio-
economic, dietary and lifestyle-related variables were 
collected at study enrolment through the use of a 
validated questionnaires. The highest educational 
attainment was categorized as follow: ‘low’ = primary 
school or lower; ‘medium’ = secondary school, ‘high’ = 
university degree or higher. Smoking was categorized as 
‘never’, ‘former’ and ‘current’ smokers based on self-
reported information. Alcohol was categorized as 
‘abstainer’, ‘occasional’ (less than 28 g/day) and 
‘habitual’ drinkers (more than 28 g/day). Physical activity 
was assessed using the Cambridge Physical Activity 
Index which combines self-reported occupational activity 
with time participating in cycling and sports. Participants 
were divided into 3 categories: ‘low’ (sedentary job and 
no recreational activity), ‘medium’ (at least one of 
physical job and less than one hour of recreational 
activity per day), and ‘high’ (sedentary job with >1 hour 
of recreational activity per day, standing or physical job 
with some recreational activity, or a heavy manual job). 
Height and weight were measured at enrolment with a 
standardized protocol, and body mass index (BMI) was 
calculated as the ratio between weight in kg and squared 
height in meters, treated as categorical variable: normal 
weight = BMI ≤ 25; overweight = 25 < BMI ≤ 30; obese 
= BMI ≥ 30 
 
Airwave - The Airwave Health Monitoring Study is an 
occupational cohort of employees of 28 police forces 
from across Great Britain. Full details of the cohort and 
methods are available in Elliott et al [2]. The study started 
recruitment in 2006 and now contains 53,280 participants. 
The study received ethical approval from the National 
Health Service Multi-Site Research Ethics Committee 
(MREC/13/NW/0588). At the baseline health screening, 
participants underwent health examination, self-
completed a computer questionnaire and blood samples in 
EDTA tubes for DNA extraction. Blood samples were 
spun at the health clinic and the biological samples were 
stored in a Thermoporter (LaminarMedica) and frozen at -
80 °C long term storage. Covariates in the analysis were 
categorised from self-report or clinical data as follows: 
Education was defined as low (completed GCSEs or 
equivalent only), medium (completed ‘A’ levels or 
equivalent only) or high (completed university or higher 
degree).  Alcohol use was classed as non-drinker, 
occasional drinker (≤ 14 alcohol units/week for women 
and ≤ 21 alcohol units/week for men) or habitual drinker 
(> 14 alcohol units/week for women and >21 alcohol 
units/week for men).  Physical activity was defined as 
low, moderate or high based on the scoring protocol of 
the International Physical Activity Questionnaire [3]. 
Smoking was categorized as ‘never’, ‘former’ and 
‘current’ smokers based on self-reported information. 
Height and weight were measured at enrolment with a 
standardized protocol, and body mass index (BMI) was 
calculated as the ratio between weight in kg and squared 
height in meters, treated as categorical variable: normal 
weight = BMI ≤ 25; overweight = 25 < BMI ≤ 30; obese 
= BMI ≥ 30 
 
The ESTHER study is an ongoing population-based 
cohort study conducted in the federal state of Saarland, 
Germany [4]. In brief, 9,949 older adults (50-75 years) 
were recruited by their general practitioners (GPs) during 
routine health check-ups (offered every two years to 
people older than 35 years in the German healthcare 
system) between 2000 and 2002, and followed up 
thereafter. During the baseline enrolment, 
epidemiological data (including socio-demographic 
characteristics, lifestyle factors, and history of major 
diseases) were collected via a standardized self-
administered questionnaire completed by participants and 
via additional reports from participants’ GPs, and 
biological samples (blood, stool, urine) were obtained and 
stored at −80 °C. Educational levels were defined as low 
[≤9 years], medium [10-11 years], and high [≥= 12 years]. 
Smoking behaviours were based on self-reported 
information and classified according to commonly used 
criteria. An ever-smoker was defined as a subject who 
had ever smoked ≥100 cigarettes during his or her 
lifetime, thus excluding rare occasional smoking. An 
ever-smoker was classified as a former smoker if he or 
she had stopped smoking for ≥1 year prior to the study. 
Body mass index (BMI) were categorized as underweight 
(<18.5 kg/m2), normal weight (18.5 to <25.0 kg/m2), 
overweight (25.0 to <30.0 kg/m2), or obese (≥30.0 
kg/m2)]. Physical activity were categorized as inactive 
(<1 hour/week of physical activity), medium/high (≥2 
hour/week of vigorous physical activity or ≥2 hour/week 
of light physical activity), or low (all others)]. Alcohol 
was categorized as abstainer (0 gram/day), occasional 
drinker (≤28 gram/day), and habitual drinkers (>28 
gram/day). Two subsets of ESTHER participants were 
selected for DNA methylation assessment in the baseline 
blood samples: Subset I consists of 1,000 participants 
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consecutively enrolled during the first 3 months of 
recruitment; Subset II consists of 864 participants 
selected for a case-cohort design for mortality analysis 
[5]. The study was approved by the ethics committees of 
the University of Heidelberg and of the Medical 
Association of Saarland. All participants provided written 
informed consent. 
 
KORA - This study is based on data from participants of 
four independent cross-sectional surveys (S1–S4) of the 
KORA (Cooperative Health Research in the Region of 
Augsburg) project between 1984 and 2001 [6], as well as 
from participants from KORA T2DM Family Study 
(T2DMFAM19 [7]), which was performed in 2001 / 
2002. All probands were from the city or region of 
Augsburg. All participants were living in Germany and 
all were of European origin. DNA methylation was 
performed using the Illumina 450K BeadChip array. The 
highest educational attainment was categorized as follow: 
‘low’ = primary school or lower; ‘medium’ = secondary 
school, ‘high’ = university degree or higher. Smoking 
was categorized as ‘never’, ‘former’ and ‘current’ 
smokers based on self-reported information. Alcohol was 
categorized as ‘abstainer’, ‘occasional’ (less than 28 
g/day) and ‘habitual’ drinkers (more than 28 g/day). 
Height and weight were measured at enrolment with a 
standardized protocol, and body mass index (BMI) was 
calculated as the ratio between weight in kg and squared 
height in meters, treated as categorical variable: normal 
weight = BMI ≤ 25; overweight = 25 < BMI ≤ 30; obese 
= BMI ≥ 30. 
 
MCCS - We used data from studies nested within the 
Melbourne Collaborative Cohort Study (Melbourne, 
Victoria, Australia), a prospective cohort study of 41,513 
healthy adult volunteers (24,469 women) aged 27–76 
years (99.3% were aged 40–69 years) at baseline between 
1990 and 1994 (MILNE, INT J EPIDEMIOL, 2017). 
DNA samples used for the present analysis were extracted 
from peripheral blood drawn at the time of recruitment 
(1990–1994). For the majority (70%) of participants, the 
DNA source was dried blood spots collected onto Guthrie 
Card Diagnostic Cellulose filter paper (Whatman plc, 
Kent, United Kingdom) and stored in airtight containers 
at room temperature. The other sources of DNA were 
peripheral blood mononuclear cells and buffy coats stored 
at −80°C for 28% and 2% participants, respectively. 
 
The study sample comprised Melbourne Collaborative 
Cohort Study participants selected as controls in nested 
case-control studies of breast, colorectal, kidney, lung, 
prostate, or urothelial cancer or mature B-cell 
malignancies [8-11]. Controls had been individually 
matched to cases on age (they had to be free of cancer at 
an age within 1 year of the age at diagnosis of the 
corresponding case), sex, country of birth, and blood 
DNA source (dried blood spot, peripheral blood 
mononuclear cells, or buffy coat). For all but the 
colorectal cancer study, controls were matched to cases 
on year of birth. For the lung cancer study, controls were 
matched on smoking status at the time of blood 
collection. 
 
Socio-economic, dietary and lifestyle-related variables 
were collected at study enrolment through the use of a 
validated questionnaires. The highest educational 
attainment was categorized as follows: ‘low’ = primary 
school or lower; ‘medium’ = secondary school, ‘high’ = 
university degree or higher. Smoking was categorized as 
‘never’, ‘former’ and ‘current’ smokers based on self-
reported information. Alcohol was categorized as 
‘abstainer’, ‘occasional’ (less than 28 g/day) and 
‘habitual’ drinkers (more than 28 g/day). Height and 
weight were measured at enrolment with a standardized 
protocol, and body mass index (BMI) was calculated as 
the ratio between weight in kg and squared height in 
meters, treated as categorical variable: normal weight = 
BMI ≤ 25; overweight = 25 < BMI ≤ 30; obese = BMI ≥ 
30. Physical activity was 1 to 4 and reflecting metabolic 
equivalents, as described in previous. Physical activity 
was defined by a summary score aimed to reflect the total 
energy expenditure as described in MacInnis et al., and 
was based on questions relating to frequency of walking, 
vigorous exercise (exercise ‘making you sweat or feel out 
of breath, and includes such activities as swimming, 
tennis, netball, athletics, and running’) and less vigorous 
exercise (exercise ‘which did not make you sweat or feel 
out of breath and includes such activities as bike riding, 
dancing, etc.’) over the last 6 months [12]. 
 
NAS - The Normative Aging Study (NAS) is an ongoing 
longitudinal male cohort established in 1963. Men were 
free of known chronic clinical conditions at enrolment 
and were subsequently invited to clinical examinations 
every 3 to 5 years [13]. At each visit, participants 
provided information on medical history, lifestyle, and 
demographic factors, and underwent a physical 
examination and laboratory tests. The NAS study was 
approved by the Institutional Review Boards (IRBs) of 
the participating institutions. Participants have provided 
written informed consent at each visit.  
 
DNA samples were collected from 1999 to 2007 from the 
675 active participants and used for DNA methylation 
analysis. We excluded participants who were not of 
European descent or had missing information on race, 
other covariates or with leukaemia or any blood cancer, 
leaving a total of 624 individuals for the analysis. 
 
At each in-person examination visit, participants provide 
demographic information and completed a questionnaire 
enquiring about their smoking status, education, alcohol 
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consumption and life-style, including a measure of 
physical activity (metabolic equivalent of task: MET).  
Anthropometric measurements (height and weight) were 
also performed with participants in undershorts and 
socks. All variables were harmonized and categorized as 
in the EPIC study, except for smoking (ever/never), 
alcohol consumption (≤2 or >2 drinks/day), and physical 
activity (≤10 MET hours/week, 10<MET hours/week or 
>25 MET hours/week). 
 
NICOLA – The Northern Ireland Cohort for the 
Longitudinal Study of Ageing is a longitudinal cohort 
representative of the non-institutionalized population of 
Northern Ireland over the age of 50 years (n=8,500) [14].  
The study which was established in 2013 has three main 
components: a computer aided personal interview 
(CAPI), a self-completion questionnaire and health 
assessment. Dietary intake was also assessed by a food 
frequency questionnaire. The CAPI was extensive in 
scope and included assessment of demographic, social 
and health-related factors. Measures of cardiovascular, 
physical, cognitive and visual function were determined 
and a biobank of biological samples collected. 
Educational attainment was categorized as follows: ‘low’ 
= primary school or lower; ‘medium’ = secondary school, 
‘high’ = higher education. Smoking was categorized as 
‘never’, ‘former’ or ‘current’ based on self-reported 
information. Alcohol was categorized as ‘abstainer’, 
‘occasional’ (on average less than one alcoholic 
beverage/day) and ‘habitual’ drinkers (on average one or 
more alcoholic beverages/day). Physical activity was 
defined as low, moderate or high based on the scoring 
protocol of the International Physical Activity 
Questionnaire (3). Physical activity was categorized as 
‘high’ = highest tertile of metabolic equivalent (MET) 
computed based on self-reported frequency and duration 
of physical activity; ‘medium’ = middle tertile of MET; 
‘low’ = lowest tertile of MET. Height and weight were 
measured at the health assessment with a standardized 
protocol, and body mass index (BMI) was calculated as 
the ratio between weight in kg and height in meters 
squared, treated as categorical variable: normal weight = 
BMI ≤ 25; overweight = 25 < BMI ≤ 30; obese = BMI ≥ 
30. 
 
Rotterdam Study  - The Rotterdam Study is a prospective 
population based-study started in 1989. It is composed of 
residents of the neighborhood of Ommoord, Rotterdam, 
the Netherlands, aged 45 years and over. Data on socio-
economic status, diet and lifestyle factors were assessed 
by standardized questionnaires, measured anthropometric 
data and blood samples collected for DNA extraction. 
Education was categorized into three groups: i) ‘low’ = 
primary school or lower; ii) ‘medium’ = secondary 
school; iii) ‘high’ = university degree or higher. Smoking 
was categorized as ‘never’, ‘former’ and ‘current’ 
smokers based on self-reported information. Physical 
activity level was measured with a self-administrated 
LASA Physical Activity questionnaire (LAPAQ). Later, 
the intensity of the reported activities was quantified 
using the metabolic equivalent of task (MET) hours per 
week, and then categorized in three groups: i) sedentary: 
<10 MET hours/week; ii) moderately active: 10–40 MET 
hours/week and iii) active: > 40 MET hours/week. 
Alcohol consumption was categorized into i) abstainer: 
consumption of 0 grams/day of alcohol, ii) moderate 
drinker: consumption > 0 grams/day and ≥ 28 grams/day, 
ii) habitual drinker: consumption > 28 grams/day. Height 
and weight were measured with a standardized protocol. 
Body mass index (BMI) was calculated as the ratio 
between weight in kg and squared height in meters, and 
then categorized in three groups: i) normal weight: BMI ≤ 
25;  ii) overweight: 25 < BMI ≤ 30; iii) obese = BMI ≥ 30 
 
SAPALDIA - Swiss Study on Air Pollution and Lung and 
Heart Disease in Adults is a population cohort in 
Switzerland initiated in 1991 recruiting 9651 random 
samples from eight cities covering geographical, 
meteorological, and cultural diversity of the population. 
The SAPALDIA cohort has been described in detail 
previously [15]. Blood samples collected at the second 
follow-up in 2010-11 and stored at -80 °C. DNA 
methylation was analyzed in the framework of 
EXPOsOMICS for a total of 402 samples selected based 
on asthma status and the availability of archived blood 
samples and covariate information. Self-reported 
education level was categorized as ‘high’ = technical 
college or university; ‘medium’ = secondary school, 
middle school or apprenticeship; ‘low’ = primary school. 
Smoking status was categorized as ‘never’ or ‘former’ 
smokers based on self-reported information. Current 
smokers were excluded. Alcohol consumption was 
categorized as ‘abstainer’ = never; ‘occasional’ = rarely, 
1-2 times per week, or several times per week; ‘habitual’ 
= once per day, twice per day, 3 times or more per day. 
Physical activity was categorized as ‘high’ = highest 
tertile of metabolic equivalent (MET) computed based on 
self-reported frequency and duration of physical activity; 
‘medium’ = middle tertile of MET; ‘low’ = lowest tertile 
of MET. Vigorous physical activity was given 6 MET 
while moderate activity 3 MET. Weight and height were 
measured during the health examination. BMI was 
computed as weight in kilogram divided by squared 
height in meter and categorized as ‘normal’ = BMI < 25; 
‘overweight’ = 25 ≤ BMI < 30; ‘obese’ = BMI ≥ 30. 
 
SKIPOGH - The Swiss Kidney Project on Genes in 
Hypertension (SKIPOGH) study is a multicenter family-
based population study initiated in 2009 to explore the 
genetic and environmental determinants of BP [16]. Study 
participants were recruited in the cantons of Bern and 
Geneva and the city of Lausanne. Recruitment began in 
www.aging-us.com 2063 AGING 
December 2009 and ended in April 2013. Inclusion 
criteria were: (i) written informed consent, (ii) minimum 
age of 18 years, (iii) Caucasian origin, and (iv) at least 
one, and preferably 3, first-degree family members also 
willing to participate. At the end of the recruitment 
period, the study population included 1,128 participants 
from 271 distinct family pedigrees. Of the individuals 
asked to participate in Bern, Geneva, and Lausanne, 21%, 
22%, and 20% agreed, respectively. The SKIPOGH study 
was approved by the ethical committees of Lausanne 
University Hospital, Geneva University Hospital, and the 
University Hospital of Bern. Data were from the first 
follow-up which started in 2013, but highest attained 
education that was collected at baseline. Covariates in the 
analysis were categorised from self-report or clinical data 
as follows: Education was defined as low (no diploma or 
mandatory school or secondary vocational training), 
medium (secondary vocational training of superior level 
or superior non-university training) or high (university 
degree).  Alcohol use was classed as non-drinker, 
occasional drinker (≤ 14 alcohol units/week for women 
and ≤ 21 alcohol units/week for men) or habitual drinker 
(> 14 alcohol units/week for women and >21 alcohol 
units/week for men).  Physical activity was defined as 
low, moderate or high based on a question about overall 
physical activity: “Please indicate on a scale from 1-10 
the physical efforts that you are doing on a daily basis, 
including those at work, during sports and your free time 
activities” [3]. Smoking was categorized as ‘never’, 
‘former’ and ‘current’ smokers based on self-reported 
information. Height and weight were measured with a 
standardized protocol, and body mass index (BMI) was 
calculated as the ratio between weight in kg and squared 
height in meters, treated as categorical variable: normal 
weight = BMI ≤ 25;  overweight = 25 < BMI ≤ 30; obese 
= BMI ≥ 30. An EDTA whole blood collection vessel was 
used (BD, Franklin Lakes, New Jersey). DNA was 
extracted using standard methods on a bead-based 
KingFisher Duo robot extraction system (ThermoFisher, 
Waltham, Massachusetts). DNA quality assessement and 
quantification was performed using a Nanodrop system 
(ThermoFisher, Waltham, Massachusetts). For bisulfite 
conversion, the protocol started with ~1.2ug of DNA 
extracted. For the PCR step: alternative incubation 
conditions was performed when using the Illumina 
Infinium® Methylation Assay (Appendix page 6 of 
bisulfite conversion protocol pdf). The final elution was 
done with 8ul of M-Elution Buffer. Processing pipeline of 
the beta methylation values was CPACOR [17]. 
 
TERRE: We used data from population-based controls of 
a case-control of Parkinson’s disease in French farmers 
[18]. We included Parkinson’s disease patients enrolled in 
the French health insurance system for farmers (MSA) 
from 62 metropolitan districts (1998-1999). We randomly 
selected eligible controls from among all MSA members 
who requested reimbursement for health expenses 
(participation rate = 83%). Controls were matched to 
cases on age, sex, and district of residency, and did not 
report cardinal signs of Parkinson’s disease. DNA was 
extracted from peripheral blood leukocytes. Education 
was defined as low (no education or primary school), 
medium (certificate level) or high (secondary school to 
university degree).  Alcohol use was classed as non-
drinker, occasional drinker (e.g., events, family 
celebrations) or habitual drinker (regularly or daily 
drinker). Physical activity was not assessed. Smoking was 
categorized as ‘never’, ‘former’ and ‘current’ smokers 
based on self-reported information. Height and weight 
were self-reported, and body mass index (BMI) was 
calculated as the ratio between weight in kg and squared 
height in meters, treated as categorical variable: normal 
weight = BMI ≤ 25; overweight = 25 < BMI ≤ 30; obese 
= BMI ≥ 30. 
 
The Irish Longitudinal Study on Ageing (TILDA) is a 
large prospective cohort study examining the social, 
economic and health circumstances of 8,175 community-
dwelling older adults aged 50 years and over resident in 
the Republic of Ireland. The sample was generated using 
a 3-stage selection process and the Irish Geodirectory as 
the sampling frame. The Irish Geodirectory is a 
comprehensive listing of all addresses in the Republic of 
Ireland, which is compiled by the national post service 
and ordnance survey Ireland. Subdivisions of district 
electoral divisions pre-stratified by socio-economic status, 
age, and geographical location, served as the primary 
sampling units. The second stage involved the selection 
of a random sample of 40 addresses from within each 
PSU resulting in an initial sample of 25,600 addresses. 
The third stage involved the recruitment of all members 
of the household aged 50 years and over. Consequently, 
the response rate was defined as the proportion of 
households including an eligible participant from whom 
an interview was successfully obtained. A response rate 
of 62% was achieved at the household level. There were 
three components to the survey. Respondents completed a 
computer-assisted personal interview and a separate self-
completion paper and pencil module which collected 
information that was considered sensitive. All participants 
were invited to undergo an independent health assessment 
at one of two national centers using trained nursing staff. 
Blood samples were taken during the clinical assessment 
with the consent of participants. A more detailed 
exposition of study design, sample selection and protocol 
is available elsewhere [19]. The present study sample 
included 500 healthy individuals: 125 for each of the four 
SES classes: stable professional, any downward mobility, 
any upward mobility, and stable unskilled (see 
socioeconomic position assessment). Buffy coat or 
peripheral blood mononuclear cells (PBMC) samples 
were available for all the individuals. Overall, after DNA 
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methylation data quality controls and sample filtering, 
490 subjects were analyzed in this study. 
 
Effects size comparison between SEMs and epigenetic 
clocks 
 
For the three epigenetic clocks, the estimated differences 
presented in Table 2 (βs) represent the change in 
biological age (in years) compared with the reference 
group. In order to make the effect sizes of the logSEM 
variable comparable with those of the three epigenetic 
clocks (i.e. expressed as years of increasing biological 
age), we re-scaled both the effect sizes and the standard 
deviations by a factor σ = σ EC/ σ SEMs, where σ EC is the 
average standard deviation of the three epigenetic clocks 
and σ SEMs is the standard deviation of the logSEM 
variable. In this way, the re-scaled effect size of logSEM 
can be interpreted as years of increasing biological age as 
is the case for the three epigenetic clocks. 
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SUPPLEMENTARY TABLES 
 
Table S1. Results of linear regressions using epigenetic aging biomarkers (WBC adjusted) as outcomes and 
lifestyle related risk factors as predictors.  
  SEMs HorvathEAA 
  Model 1 Model 2 Model 1 Model 2 
Education 
(ref: High) 
Medium 0.28 (0.06; 0.49)* 0.23 (-0.02; 0.48)+ 0.1 (-0.08; 0.28)  0.09 (-0.1; 0.29)  
High 0.32 (0.09; 0.54)** 0.27 (0.04; 0.5)* 0.19 (-0.01; 0.38)+ 0.14 (-0.06; 0.34)  
Smoking 
(ref: Never) 
Former 0.24 (0.08; 0.4)** 0.28 (0.12; 0.43)*** 0.18 (0.02; 0.35)* 0.17 (0.01; 0.32)* 
Current 0.54 (0.32; 0.76)*** 0.54 (0.32; 0.77)*** 0.12 (-0.07; 0.31)  0.1 (-0.1; 0.3)  
Obesity (ref: 
BMI < 25) 
BMI < 30 0.02 (-0.17; 0.2)  0 (-0.18; 0.17)  0.37 (0.22; 0.52)*** 0.35 (0.19; 0.5)*** 
BMI ≥ 30 -0.11 (-0.33; 0.1)  -0.13 (-0.34; 0.08)  0.45 (0.27; 0.63)*** 0.44 (0.25; 0.62)*** 
Alcohol (ref: 
Abstainer) 
Occasional -0.16 (-0.35; 0.03)+ -0.14 (-0.33; 0.04)  -0.01 (-0.19; 0.16)  0.02 (-0.16; 0.19)  
Habitual 0.18 (-0.06; 0.42)  0.13 (-0.12; 0.38)  0.2 (-0.03; 0.44)+ 0.26 (0.03; 0.49)* 
Physical 
activity (ref: 
High) 
Medium -0.04 (-0.26; 0.18)  -0.06 (-0.24; 0.13)  0.08 (-0.08; 0.24)  0.07 (-0.09; 0.24)  
Low 0.03 (-0.27; 0.33)  -0.02 (-0.3; 0.26)  0.22 (0.05; 0.4)* 0.19 (0.01; 0.37)* 
  HannumEAA LevineEAA 
  Model 1 Model 2 Model 1 Model 2 
Education 
(ref: High) 
Medium 0.3 (0.14; 0.46)*** 0.24 (0.06; 0.42)** 0.36 (0.05; 0.68)* 0.16 (-0.23; 0.55)  
High 0.32 (0.16; 0.48)*** 0.28 (0.12; 0.43)*** 0.85 (0.53; 1.17)*** 0.57 (0.25; 0.89)*** 
Smoking 
(ref: Never) 
Former 0.15 (0.03; 0.26)* 0.1 (-0.01; 0.22)+ 0.68 (0.49; 0.87)*** 0.58 (0.38; 0.78)*** 
Current 0.46 (0.26; 0.65)*** 0.4 (0.21; 0.6)*** 1.62 (1.35; 1.89)*** 1.48 (1.19; 1.77)*** 
Obesity (ref: 
BMI < 25) 
BMI < 30 0.2 (0.08; 0.32)** 0.19 (0.06; 0.32)** 0.59 (0.3; 0.88)*** 0.5 (0.26; 0.74)*** 
BMI ≥ 30 0.25 (0.11; 0.39)*** 0.24 (0.1; 0.39)*** 1.25 (0.92; 1.58)*** 1.18 (0.87; 1.48)*** 
Alcohol (ref: 
Abstainer) 
Occasional -0.02 (-0.15; 0.11)  0.05 (-0.09; 0.18)  -0.07 (-0.33; 0.19)  0.09 (-0.14; 0.32)  
Habitual 0.24 (0.06; 0.42)** 0.3 (0.1; 0.49)** 0.91 (0.61; 1.2)*** 0.99 (0.66; 1.31)*** 
Physical 
activity (ref: 
High) 
Medium 0.09 (-0.07; 0.24)  0.07 (-0.08; 0.22)  0.17 (-0.17; 0.52)  0.12 (-0.13; 0.37)  
Low 0.13 (-0.11; 0.37)  0.07 (-0.19; 0.33)  0.49 (-0.01; 0.98)+ 0.27 (-0.13; 0.67)  
*** p < 0.001; ** p < 0.01; * p < 0.05; + p < 0.10 
Model 1 includes age, sex, and cohort specific covariates; Model 2 includes additional adjustment for education, smoking, 
BMI, alcohol and physical activity.  
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Table S2. Interaction with age and sex. 
  SEMs HorvathEAA 
  age sex age sex 
Education (ref: High) 
Medium 0.02 (-0.01; 0.05)  -0.08 (-0.16; 0)+ 0 (-0.03; 0.03)  0.02 (-0.39; 0.43) 
High 0.03 (0; 0.05)+ -0.05 (-0.13; 0.02) -0.01 (-0.04; 0.02)  0.19 (-0.22; 0.59) 
Smoking (ref: Never) 
Former 0.01 (0; 0.03)  -0.07 (-0.15; 0)+ 0.02 (0; 0.04)* 0 (-0.4; 0.4) 
Current 0.04 (0.01; 0.06)** -0.06 (-0.14; 0.02) 0.03 (0.01; 0.05)* 0.21 (-0.19; 0.61) 
Obesity (ref: BMI < 25) 
BMI < 30 0.03 (0.01; 0.06)* -0.06 (-0.14; 0.02) 0 (-0.03; 0.03)  0.03 (-0.37; 0.43) 
BMI ≥ 30 0.02 (0; 0.04)+ -0.05 (-0.13; 0.02) 0 (-0.02; 0.02)  0.23 (-0.17; 0.63) 
Alcohol (ref: Abstainer) 
Occasional -0.01 (-0.04; 0.01)  -0.08 (-0.15; 0)+ -0.01 (-0.03; 0.02)  0.01 (-0.39; 0.41) 
Habitual 0.01 (-0.01; 0.04)  -0.06 (-0.14; 0.02) 0 (-0.02; 0.03)  0.19 (-0.21; 0.59) 
Physical activity (ref: 
High) 
Medium 0 (-0.03; 0.02)  -0.08 (-0.16; 0)+ -0.02 (-0.04; 0)  0 (-0.4; 0.4) 
Low 0 (-0.02; 0.03)  -0.06 (-0.14; 0.02) -0.01 (-0.03; 0.02)  0.16 (-0.24; 0.57) 
  HannumEAA LevineEAA 
  Age Sex Age sex 
Education (ref: High) 
Medium 0.01 (-0.01; 0.02)  0.03 (-0.32; 0.38) 0 (-0.04; 0.03)  0.13 (-0.44; 0.7) 
High -0.02 (-0.04; 0)* 0.1 (-0.22; 0.43) -0.01 (-0.05; 0.02)  -0.08 (-0.74; 0.59) 
Smoking (ref: Never) 
Former 0.01 (0; 0.03)* -0.01 (-0.37; 0.35) 0.02 (0; 0.04)+ 0.09 (-0.47; 0.65) 
Current 0.04 (0.02; 0.06)*** 0.11 (-0.21; 0.43) 0.03 (0; 0.07)+ -0.06 (-0.72; 0.6) 
Obesity (ref: BMI < 25) 
BMI < 30 -0.01 (-0.03; 0.02)  0.05 (-0.29; 0.4) 0 (-0.03; 0.04)  0.11 (-0.45; 0.67) 
BMI ≥ 30 -0.01 (-0.02; 0.01)  0.13 (-0.19; 0.46) 0 (-0.03; 0.03)  -0.04 (-0.7; 0.63) 
Alcohol (ref: Abstainer) 
Occasional 0 (-0.02; 0.02)  0.03 (-0.31; 0.37) 0.01 (-0.02; 0.04)  0.08 (-0.48; 0.64) 
Habitual 0 (-0.02; 0.02)  0.1 (-0.22; 0.43) 0.01 (-0.02; 0.05)  -0.08 (-0.75; 0.58) 
Physical activity (ref: 
High) 
Medium 0 (-0.02; 0.01)  0 (-0.35; 0.35) -0.03 (-0.06; 0)+ 0.12 (-0.44; 0.68) 
Low 0 (-0.02; 0.02)  0.07 (-0.25; 0.4) 0 (-0.04; 0.03)  -0.07 (-0.73; 0.59) 
*** p < 0.001; ** p < 0.01; * p < 0.05; + p < 0.10 
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Table S3. Results of the enrichment analyses using the classification of the UCSC Genome Browser for the 
relationship with CpG islands, open chromatin state and DNase hypersensitivity.  
Relation to CpG island according to UCSC Genome 
Browser Permutation based p-value for enrichment 
Shores 0.02 
Open chromatin evidence 0.03 
CpG Island 0.27 
Shelves 1 
Non CpG Island 1 
DNase hypersensitivity evidence 1 
P-values were computed according to the algorithm implemented in the regioneR R package. 
 
 
Table S4. Results of the enrichment analyses using the ENCODE classification for chromatin states in embryonic 
stem cell (H1-hESC).  
Chromatin state according to ENCODE ChIP-Seq Permutation based p-value for enrichment 
Heterochromatin / Low signal / CNV < 0.0001 
Inactive / Poised promoter < 0.0001 
Polycomb Repressed 0.001 
Transcriptional elongation / Transition 1 
Weak Transcribed 1 
Active promoter 1 
Weak promoter 1 
Strong enhancer 1 
Weak / Poised enhancer 1 
Insulator 1 
Non regulatory elements 1 
P-values were computed according to the algorithm implemented in the regioneR R package.  
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Table S5. Results of the enrichment analyses using the ENCODE classification for 58 protein TFBS in non-treated 
embryonic stem cell (H1-hESC).  
Transcription Factor Lab Permutation based p-value for enrichment 
EZH2 Broad < 0.0001 
SUZ12 USC < 0.0001 
CtBP2 USC 0.15 
CHD1 Broad 0.27 
NRSF HudsonAlpha 0.88 
BCL11A HudsonAlpha 1 
c-Myc UT-A 1 
POU5F1 HudsonAlpha 1 
MafK Stanford 1 
RXRA HudsonAlpha 1 
NANOG HudsonAlpha 1 
CHD1 Stanford 1 
c-Jun Stanford 1 
RFX5 Stanford 1 
HDAC2 HudsonAlpha 1 
FOSL1 HudsonAlpha 1 
TCF12 Stanford 1 
CEBPB HudsonAlpha 1 
TEAD4 USC 1 
Max UT-A 1 
CTCF Stanford 1 
Rad21 Stanford 1 
Rad21 HudsonAlpha 1 
BRCA1 Stanford 1 
CTCF Broad 1 
CTCF Stanford 1 
USF2 Stanford 1 
SP2 HudsonAlpha 1 
JARID1A Broad 1 
SIX5 HudsonAlpha 1 
SRF HudsonAlpha 1 
USF-1 HudsonAlpha 1 
ATF2 HudsonAlpha 1 
JunD Stanford 1 
ATF3 HudsonAlpha 1 
Bach1 Stanford 1 
Nrf1 Stanford 1 
c-Myc Stanford 1 
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JunD HudsonAlpha 1 
GABP HudsonAlpha 1 
GTF2F1 Stanford 1 
p300 HudsonAlpha 1 
Egr-1 HudsonAlpha 1 
Mxi1 Stanford 1 
CHD2 Stanford 1 
Znf143 Stanford 1 
Sin3Ak-20 HudsonAlpha 1 
RBBP5 Broad 1 
YY1 HudsonAlpha 1 
SP1 HudsonAlpha 1 
SP4 HudsonAlpha 1 
TAF7 HudsonAlpha 1 
TBP Stanford 1 
Pol2 HudsonAlpha 1 
SIN3A Stanford 1 
Pol2 UT-A 1 
TAF1 HudsonAlpha 1 
Pol2 HudsonAlpha 1 
P-values were computed according to the algorithm implemented in the regioneR R package. 
 
